VANCOUVER, British Columbia--(BUSINESS WIRE)--Dec. 2, 2004--Meridian Co., Ltd. ("Meridian") (OTCBB:MRDAF - News), is pleased to announce that its Digital Pulse Analyzer ("DPA") technology will be used to test thousands of medical attendees at the 12th Annual World Congress on Anti-Aging Medicine hosted by the American Academy for Anti-Aging Medicine ("A4M"). There is expected to be 5,000 participants at this event and 250 exhibitors.

More About: A4M

A4M is the largest and most influential academic and industry event worldwide in the space of preventative medicine and bio-medical technologies. This new medical specialty ($30 billion Anti-Aging US Marketplace-Dateline NBC, 2001), is expected to grow to $41.94 Billion by 2006, reflecting an average annual rate (AAGR) of 9% ("Drugs and Cosmetics for Aging Boomers," Business Communications Company, Inc., 2002).

"Today's mature adults (boomers) control more than $7 trillion in wealth in the United States" (Harvard Business Review, March 2004), "or 70% of all U.S. wealth. Further, they bring in $2 trillion in annual income, and account for 50% of all discretionary spending", notes Ken Dychtwald PhD (Associated Press, March 7, 2004).

More About: Digital Pulse Analyzer ("DPA")

The "DPA" accurately measures the elasticity of small and large arteries and provides health care practitioners with critical information regarding arterial aging. This FDA approved device is inexpensive, non-invasive, and can provide results in minutes. Accumulating evidence suggests that abnormalities in the pulsatile characteristics of arteries occur early in the disease process associated with increased cardiovascular risk, and can be favorably modified by therapeutic interventions.

The Company feels that use of the "DPA" can help caregivers reduce cardiovascular disease in their patient populations through early detection and prevention, and ultimately assist to decrease the associated financial costs placed on the health care industry. Cardiovascular disease is the #1 killer in the United States with an estimated economic cost of approximately $298 billion.

More About: Meridian

Meridian is an established leader in the research/development, manufacturing, and sales of integrative medical diagnostic equipment. The company sells its products and equipment to a wide array of customers in the global health care industry. The company presently holds a total of 18 worldwide patents on its technology, and has received FDA, as well as other international regulatory approvals for many of its products.

Meridian is committed to the ongoing global research and advancement of integrative medical products that contribute to the better health of humanity.

Website (Korean): www.meridian.co.kr

Website (North America): meridianmedical.ca

---

Contact:

     Meridian Co., Ltd.
     Greg Worobec
     1-877-738-8119
     Email: 

 

---

Source: Meridian Co., Ltd.